The Use of Exhaled Nitric Oxide in Conjunction With the Asthma Control Test to Determine Asthma Control in Pediatric Patients
Stopped early
Conditions studied: Asthma
In brief
The purpose of this study is to determine if exhaled nitric oxide (eNO) levels will be increased in pediatric patients with uncontrolled asthma as determined by the Asthma Control Test (ACT). During the study the investigators will also examine if the combination of eNO and ACT will better predict asthma control that either tool alone when compared to a medical provider's assessment of the patient's asthma control.
Key facts
- Study ID
- NCT00575445
- Run by
- Akron Children's Hospital
- People needed
- 100
- Starts
- 2007-11-01
- Expected to finish
- 2015-03-01
- Last updated by the study team
- 2015-03-25
Who can join
Age: 6 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Clinical diagnosis of asthma by pediatric pulmonologist
- Age 6-18 years
You may not qualify if…
- Age <6 years or >18 years
- history of bronchopulmonary dysplasia
- history of cystic fibrosis
- history of primary ciliary dyskinesia
- current acute asthma exacerbation
- current acute viral upper respiratory infection
- recent ingestion of nitrate-rich foods
Where it is running
- Akron Children's Hospital — Akron, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.